India formulations business grew 14.7% YoY with recovery in industry growth from COVID-19 impact
Acquisition of one of China’s leading crop protection producers, bolstering ADAMA’s operations in China and its global product offering
US revenues were sequentially stable at US$370mn with steady performance in the specialty portfolio
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
The company reported total income of Rs.24774.63 crores during the 12 months period ended March 31, 2021
The company has posted net profit of Rs.56.39 crores in FY2020-21
Creating a system to supply high-performance polypropylene and bolstering circular economy-related efforts
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website
The GMP certificate is valid for three years until April 2024.
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
The company reported total income of Rs.581.06 crores during FY 2020-21
The company reported total income of Rs.1106.80 crores during the 12 months period ended March 31, 2021 a
The company has reported total income of Rs.2663.47 crores during FY 2020-21
The company has reported total income of Rs.1871.12 crores during FY 2020-21
For the year ended March 31, 2021, consolidated revenue was at Rs. 10,943.9 crores as against Rs. 10,641 crores, recording an increase of 2.8% over the previous corresponding period
To be used by the chemical industry, it helps eliminate the challenges posed by the chemical when sourced through traditional processes
Consolidated FY21 revenue grew by 24% and crossed Rs. 5,800 crores whereas net profit jumped by 357% and crossed Rs. 400 crores
The agreement applies to the drum business for TFE, TFA, TFAH, TA and TAA in Germany, France, Switzerland and Austria
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
Subscribe To Our Newsletter & Stay Updated
